clinical
Articles tagged with “clinical”
MADRS vs PHQ-9: How Ketamine Trials Measure Response
MADRS and PHQ-9 track ketamine's effect on depression differently. Compare response and remission thresholds and see what to ask your prescriber.
What PHQ-9 Score Change Counts as Real Ketamine Improvement
A 5-point PHQ-9 drop is the usual threshold for meaningful change, and 50% is response. See how these apply to low-dose ketamine tracking in 2026.
Ketamine Dissociation and Antidepressant Response Explained
Learn what evidence says about ketamine dissociation and antidepressant response, including what clinicians monitor. Explore protocols.
Ketamine Remission Criteria for Depression Explained
Ketamine remission criteria for depression rely on standardized scales like MADRS and HAM-D. See the score thresholds, evidence quality, and what remission means in practice.
Low-Dose Ketamine Eligibility: Who Qualifies for Treatment
Learn the diagnosis, screening, and contraindication factors that determine low-dose ketamine eligibility, and see what to ask your clinician.
Low-Dose Ketamine for Late-Life Depression: Medications
Learn how clinicians assess low-dose ketamine for late-life depression with multiple medications, risks, monitoring, and questions to ask.
Ketamine Therapy for Older Adults: Safety Considerations
What older adults and families should know about ketamine therapy safety, blood pressure monitoring, drug interactions, and clinical evidence.
How to Prepare for Your First Ketamine Therapy Session
A comprehensive patient-oriented guide to preparing for an initial ketamine treatment session, covering what to expect, pre-treatment medical requirements, medication considerations, practical logistics, and strategies for optimizing treatment outcomes.
Contact Low Dose Ketamine
Send corrections, provider questions, or advertising inquiries.